Aurobindo Pharma Limited has informed the Exchange regarding a press release dated December 09, 2020, titled "Press Release on USFDA approval for Dexmedetomidine HCL in 0.9% Sodium Chloride Injection".
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated December 09, 2020, titled "Press Release on USFDA approval for Dexmedetomidine HCL in 0.9% Sodium Chloride Injection".